Literature DB >> 27714411

How cardiomyocytes sense pathophysiological stresses for cardiac remodeling.

Zaffar K Haque1, Da-Zhi Wang2.   

Abstract

In the past decades, the cardiovascular community has laid out the fundamental signaling cascades that become awry in the cardiomyocyte during the process of pathologic cardiac remodeling. These pathways are initiated at the cell membrane and work their way to the nucleus to mediate gene expression. Complexity is multiplied as the cardiomyocyte is subjected to cross talk with other cells as well as a barrage of extracellular stimuli and mechanical stresses. In this review, we summarize the signaling cascades that play key roles in cardiac function and then we proceed to describe emerging concepts of how the cardiomyocyte senses the mechanical and environmental stimuli to transition to the deleterious genetic program that defines pathologic cardiac remodeling. As a highlighting example of these processes, we illustrate the transition from a compensated hypertrophied myocardium to a decompensated failing myocardium, which is clinically manifested as decompensated heart failure.

Entities:  

Keywords:  Cardiomyopathy; Gene expression; Heart failure; MicroRNAs; Signaling pathway; Transcription

Mesh:

Year:  2016        PMID: 27714411      PMCID: PMC6990138          DOI: 10.1007/s00018-016-2373-0

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  153 in total

Review 1.  Transcriptional regulation by calcium, calcineurin, and NFAT.

Authors:  Patrick G Hogan; Lin Chen; Julie Nardone; Anjana Rao
Journal:  Genes Dev       Date:  2003-09-15       Impact factor: 11.361

Review 2.  The Anrep effect: 100 years later.

Authors:  Horacio E Cingolani; Néstor G Pérez; Oscar H Cingolani; Irene L Ennis
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-11-16       Impact factor: 4.733

3.  RhoA protects the mouse heart against ischemia/reperfusion injury.

Authors:  Sunny Yang Xiang; Davy Vanhoutte; Dominic P Del Re; Nicole H Purcell; Haiyun Ling; Indroneal Banerjee; Julie Bossuyt; Richard A Lang; Yi Zheng; Scot J Matkovich; Shigeki Miyamoto; Jeffery D Molkentin; Gerald W Dorn; Joan Heller Brown
Journal:  J Clin Invest       Date:  2011-07-11       Impact factor: 14.808

Review 4.  Renal neurohormonal regulation in heart failure decompensation.

Authors:  Sofia Jönsson; Mediha Becirovic Agic; Fredrik Narfström; Jacqueline M Melville; Michael Hultström
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-06-11       Impact factor: 3.619

5.  Therapeutic inhibition of miR-208a improves cardiac function and survival during heart failure.

Authors:  Rusty L Montgomery; Thomas G Hullinger; Hillary M Semus; Brent A Dickinson; Anita G Seto; Joshua M Lynch; Christianna Stack; Paul A Latimer; Eric N Olson; Eva van Rooij
Journal:  Circulation       Date:  2011-09-06       Impact factor: 29.690

6.  Polycystin-1 Is a Cardiomyocyte Mechanosensor That Governs L-Type Ca2+ Channel Protein Stability.

Authors:  Zully Pedrozo; Alfredo Criollo; Pavan K Battiprolu; Cyndi R Morales; Ariel Contreras-Ferrat; Carolina Fernández; Nan Jiang; Xiang Luo; Michael J Caplan; Stefan Somlo; Beverly A Rothermel; Thomas G Gillette; Sergio Lavandero; Joseph A Hill
Journal:  Circulation       Date:  2015-04-17       Impact factor: 29.690

Review 7.  Chromatin modifications remodel cardiac gene expression.

Authors:  Prabhu Mathiyalagan; Samuel T Keating; Xiao-Jun Du; Assam El-Osta
Journal:  Cardiovasc Res       Date:  2014-05-08       Impact factor: 10.787

8.  Effects of mechanical stress and carvedilol in lamin A/C-deficient dilated cardiomyopathy.

Authors:  Suchitra Chandar; Li Sze Yeo; Christiana Leimena; Ju-Chiat Tan; Xiao-Hui Xiao; Vesna Nikolova-Krstevski; Yoshinori Yasuoka; Margaret Gardiner-Garden; Jianxin Wu; Scott Kesteven; Lina Karlsdotter; Shweta Natarajan; Arthur Carlton; Stephen Rainer; Michael P Feneley; Diane Fatkin
Journal:  Circ Res       Date:  2009-12-17       Impact factor: 17.367

9.  Mouse model carrying H222P-Lmna mutation develops muscular dystrophy and dilated cardiomyopathy similar to human striated muscle laminopathies.

Authors:  Takuro Arimura; Anne Helbling-Leclerc; Catherine Massart; Shaida Varnous; Florence Niel; Emmanuelle Lacène; Yves Fromes; Marcel Toussaint; Anne-Marie Mura; Dagmar I Keller; Helge Amthor; Richard Isnard; Marie Malissen; Ketty Schwartz; Gisèle Bonne
Journal:  Hum Mol Genet       Date:  2004-11-17       Impact factor: 6.150

10.  Insulin-like growth factor 1 alleviates high-fat diet-induced myocardial contractile dysfunction: role of insulin signaling and mitochondrial function.

Authors:  Yingmei Zhang; Ming Yuan; Katherine M Bradley; Feng Dong; Piero Anversa; Jun Ren
Journal:  Hypertension       Date:  2012-01-23       Impact factor: 9.897

View more
  15 in total

1.  The cardiac syndecan-4 interactome reveals a role for syndecan-4 in nuclear translocation of muscle LIM protein (MLP).

Authors:  Sabrina Bech Mathiesen; Marianne Lunde; Jan Magnus Aronsen; Andreas Romaine; Anita Kaupang; Marita Martinsen; Gustavo Antonio de Souza; Tuula A Nyman; Ivar Sjaastad; Geir Christensen; Cathrine Rein Carlson
Journal:  J Biol Chem       Date:  2019-04-09       Impact factor: 5.157

Review 2.  Cell-based therapies for the treatment of myocardial infarction: lessons from cardiac regeneration and repair mechanisms in non-human vertebrates.

Authors:  Paul Palmquist-Gomes; José María Pérez-Pomares; Juan Antonio Guadix
Journal:  Heart Fail Rev       Date:  2019-01       Impact factor: 4.214

3.  NLRP3 deficiency accelerates pressure overload-induced cardiac remodeling via increased TLR4 expression.

Authors:  Fangfang Li; Hao Zhang; Lu Yang; Hui Yong; Qingqing Qin; Mengtong Tan; Luhong Xu; Kai Liang; Jing Zong; Wenhao Qian
Journal:  J Mol Med (Berl)       Date:  2018-08-29       Impact factor: 4.599

4.  Pediatric and adult dilated cardiomyopathy represent distinct pathological entities.

Authors:  Meghna D Patel; Jayaram Mohan; Caralin Schneider; Geetika Bajpai; Enkhsaikhan Purevjav; Charles E Canter; Jeffrey Towbin; Andrea Bredemeyer; Kory J Lavine
Journal:  JCI Insight       Date:  2017-07-20

5.  Andrographolide Protects against Aortic Banding-Induced Experimental Cardiac Hypertrophy by Inhibiting MAPKs Signaling.

Authors:  Qing Q Wu; Jian Ni; Ning Zhang; Hai H Liao; Qi Z Tang; Wei Deng
Journal:  Front Pharmacol       Date:  2017-11-14       Impact factor: 5.810

Review 6.  Pharmacological Modulation of Cardiac Remodeling after Myocardial Infarction.

Authors:  Wei Zhao; Jia Zhao; Jianhui Rong
Journal:  Oxid Med Cell Longev       Date:  2020-12-30       Impact factor: 6.543

7.  NLRP3-mediated pyroptosis aggravates pressure overload-induced cardiac hypertrophy, fibrosis, and dysfunction in mice: cardioprotective role of irisin.

Authors:  Rongchuan Yue; Zaiyong Zheng; Yu Luo; Xiaobo Wang; Mingming Lv; Dan Qin; Qingqing Tan; Yulong Zhang; Tao Wang; Houxiang Hu
Journal:  Cell Death Discov       Date:  2021-03-15

Review 8.  Mechanical regulation of gene expression in cardiac myocytes and fibroblasts.

Authors:  Jeffrey J Saucerman; Philip M Tan; Kyle S Buchholz; Andrew D McCulloch; Jeffrey H Omens
Journal:  Nat Rev Cardiol       Date:  2019-06       Impact factor: 32.419

9.  Cardiomyocyte gene programs encoding morphological and functional signatures in cardiac hypertrophy and failure.

Authors:  Seitaro Nomura; Masahiro Satoh; Takanori Fujita; Tomoaki Higo; Tomokazu Sumida; Toshiyuki Ko; Toshihiro Yamaguchi; Takashige Tobita; Atsuhiko T Naito; Masamichi Ito; Kanna Fujita; Mutsuo Harada; Haruhiro Toko; Yoshio Kobayashi; Kaoru Ito; Eiki Takimoto; Hiroshi Akazawa; Hiroyuki Morita; Hiroyuki Aburatani; Issei Komuro
Journal:  Nat Commun       Date:  2018-10-30       Impact factor: 14.919

10.  The 5-Lipoxygenase Inhibitor Zileuton Protects Pressure Overload-Induced Cardiac Remodeling via Activating PPARα.

Authors:  Qing-Qing Wu; Wei Deng; Yang Xiao; Jiao-Jiao Chen; Chen Liu; Juan Wang; Yankai Guo; Mingxia Duan; Zhulan Cai; Saiyang Xie; Yuan Yuan; Qizhu Tang
Journal:  Oxid Med Cell Longev       Date:  2019-11-03       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.